Skip to main content
. 2021 Apr 2;3(3):378–385.e1. doi: 10.1016/j.xkme.2021.01.009

Table 2.

Association of Predictors for Change in eGFR Post–LVAD Implantation in Univariable and Multivariable Analysis

Variablea Univariable Analysis
Multivariable Analysis
1 mo (n = 131)
1 mo (n = 131)
3 mo (n = 127)
6 mo (n = 106)
12 mo (n = 66)
β Coefficient (95% CI) β Coefficient (95% CI) β Coefficient (95% CI) β Coefficient (95% CI) β Coefficient (95% CI)
Age −4.14 (−7.79 to −0.49) −7.14 (−11.10 to −3.17)b −4.76 (−8.93 to −0.59)b −3.90 (−7.86 to 0.07) −5.60 (−9.50 to −1.69)b
Male sex 7.21 (−2.63 to 17.04) 3.33 (−5.53 to 12.19) 6.27 (−3.21 to 15.76) 1.49 (−7.84 to 10.81) 8.31 (−1.55 to 18.17)
African American −3.37 (−13.46 to 6.72) −3.85 (−12.59 to 4.88) 0.07 (−9.28 to 9.41) −5.87 (−15.39 to 3.66) 0.23 (−9.17 to 9.64)
Diabetes mellitus −8.34 (−15.77 to −0.91) −10.36 (−17.74 to −2.99)b −3.57 (−11.47 to 4.34) 1.01 (−6.62 to 8.64) 4.42 (−4.11 to 12.96)
Inotropes in hospital vs not receiving inotropes 12.97 (2.57 to 23.37) 5.07 (−4.53 to 14.66) 7.83 (−2.14 to 17.80) 2.58 (−6.69 to 11.85) 2.16 (−8.22 to 12.54)
Log SUN (SD = 0.23 log units) 5.28 (1.68 to 8.89) 2.84 (−1.50 to 7.18) 1.13 (−3.45 to 5.71) −1.67 (−5.98 to 2.63) −3.05 (−8.40 to 2.30)
Log bilirubin (SD = 0.32 log units) 5.84 (2.25 to 9.42) 2.31 (−1.21 to 5.83) −0.13 (−3.86 to 3.60) 2.48 (−1.09 to 6.04) 4.00 (0.18 to 7.82)b
Log ALT (SD = 0.29 log units) 4.28 (0.30 to 8.27) 3.29 (−0.15 to 6.72) 2.27 (−1.47 to 6.01) −0.41 (−3.71 to 2.87) −1.71 (−5.95 to 2.54)
Pre-LVAD eGFR −4.67 (−8.30 to −1.04) −7.72 (−12.34 to −3.10)b −8.54 (−13.43 to −3.66)b −10.16 (−14.76 to −5.56)b −9.71 (−14.48 to −4.93)b
Pre-LVAD creatinine 5.56 (1.97 to 9.15)

Abbreviations: ALT, alanine aminotransferase; eGFR, estimated glomerular filtration rate; LVAD, left ventricular assist device; SD, standard deviation; SUN, serum urea nitrogen.

a

Continuous variables are reported per 1 SD increase.

b

Values in multivariable analysis have P < 0.05.